Degarelix

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 365 publications

Resting state functional connectivity in pedophilic disorder and degarelix treatment.

Resting state functional connectivity in pedophilic disorder and degarelix treatment.

Journal: Acta neuropsychiatrica

Published: April 01, 2026

Resting state functional connectivity in paedophilic disorder and degarelix treatment.

Resting state functional connectivity in paedophilic disorder and degarelix treatment.

Journal: Acta neuropsychiatrica

Published: April 01, 2026

Comparative preclinical assessment of relugolix tablets and relugolix intravenous injection.

Comparative preclinical assessment of relugolix tablets and relugolix intravenous injection.

Journal: Scientific reports

Published: March 25, 2026

Interstitial lung disease associated with antiandrogen agents: a pharmacovigilance study based on FDA adverse event reporting system.

Interstitial lung disease associated with antiandrogen agents: a pharmacovigilance study based on FDA adverse event reporting system.

Journal: International urology and nephrology

Published: March 17, 2026

Fatal Interstitial Pneumonitis During Combined Degarelix, Darolutamide, and Docetaxel Therapy for Metastatic Prostate Cancer.

Fatal Interstitial Pneumonitis During Combined Degarelix, Darolutamide, and Docetaxel Therapy for Metastatic Prostate Cancer.

Journal: Cureus

Published: March 09, 2026

Failure of a LHRH agonist in metastatic prostate cancer: a case report and review of literature.

Failure of a LHRH agonist in metastatic prostate cancer: a case report and review of literature.

Journal: Cancer chemotherapy and pharmacology

Published: March 07, 2026

Effects of a GnRH antagonist on antral follicular development and ovarian hemodynamics in cycling ewes.

Effects of a GnRH antagonist on antral follicular development and ovarian hemodynamics in cycling ewes.

Journal: The Journal of reproduction and development

Published: February 15, 2026

Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer.

Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer.

Journal: Journal for immunotherapy of cancer

Published: February 13, 2026

Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study.

Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Diagnosis of Prostate Cancer via Transanal Endoscopic Ultrasound-Guided Fine-Needle Biopsy in a Patient With Bone Lesions and a Rapid Clinical Response to Enzalutamide Plus Degarelix.

Diagnosis of Prostate Cancer via Transanal Endoscopic Ultrasound-Guided Fine-Needle Biopsy in a Patient With Bone Lesions and a Rapid Clinical Response to Enzalutamide Plus Degarelix.

Journal: Cureus

Published: December 31, 2025

Disproportionality analysis of adverse events associated with degarelix: a real-world study from the FDA Adverse Event Reporting System (FAERS) database.

Disproportionality analysis of adverse events associated with degarelix: a real-world study from the FDA Adverse Event Reporting System (FAERS) database.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 29, 2025

Dual case insights shaping a new protocol for post-menopausal hirsutism.

Dual case insights shaping a new protocol for post-menopausal hirsutism.

Journal: JCEM case reports

Published: December 18, 2025

Showing 1-12 of 365

Last Updated: 06/30/2026